TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Tech Stocks

    Valeant Pharmaceuticals Intl Inc. on Fire to Start the Year

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has made some huge sales in the new year, helping the company to offload some…

    Read more »

    The Motley Fool
    Investing

    On the Move! Valeant Pharmaceuticals Intl Inc. Rises Again

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) announced the sale of some non-core assets this week which will help pay down the…

    Read more »

    Investing

    Valeant Pharmaceuticals Intl Inc. Just Sold Over US$2 Billion in Assets: What Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is finally selling assets, but the proceeds don't cover enough of the mountain of debt…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical Intl Inc. Just Raised its Drug Prices Again

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) is doing everything it can to raise money to pay back its debt. It's selling…

    Read more »

    The Motley Fool
    Investing

    3 CEOs Who Actually Earn Their Pay

    The former CEO of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Michael Pearson, was the highest-paid CEO in Canada at $182.9 million.…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Stock at the Top of My List!

    Going into 2017, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are at the top of my watch list.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Will Fail to Re-Invent Itself

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had a horrible year, and I believe the stock is far from rallying.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Stay on the Sidelines

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could experience wonderful growth, but for now, it's best to avoid it because it is…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Buy Now, Say Analysts

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been hit hard by recent scandals and poses significant speculative risk to investors. At…

    Read more »

    The Motley Fool
    Energy Stocks

    Valeant Pharmaceuticals Intl Inc. vs. Baytex Energy Corp.: Which Is a Better Bet?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Baytex Energy Corp. (TSX:BTE)(NYSE:BTE) are two of Canada's fallen stars. Is one about to…

    Read more »

    The Motley Fool
    Investing

    Saving Face at Valeant Pharmaceuticals Intl Inc.

    Is the fate of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) really in its own hands?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Year in Review

    Few companies had a memorable 2016 as much as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Here's a look at how the…

    Read more »